Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in HIV-1 Treatment-Naive (TN) Patients in France - Sorbonne Université Access content directly
Journal Articles Expert Review of Pharmacoeconomics & Outcomes Research Year : 2018
No file

Dates and versions

hal-03793518 , version 1 (01-10-2022)

Identifiers

Cite

Gilles Pialoux, Anne-Geneviève Marcelin, Hélène Cawston, Caroline Guilmet, Laurent Finkielsztejn, et al.. Cost-Effectiveness of Dolutegravir/Abacavir/Lamivudine in HIV-1 Treatment-Naive (TN) Patients in France. Expert Review of Pharmacoeconomics & Outcomes Research, 2018, 18 (1), pp.83--91. ⟨10.1080/14737167.2017.1359542⟩. ⟨hal-03793518⟩
19 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More